Gara Jalqabaatti › Kansarii Pancreas › California › Los Angeles
Qorannoo klinikaalii Kansarii Pancreas Los Angeles, CA keessatti
Qorannoo 35 Kansarii Pancreas f Los Angeles fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Research Site, Los Angeles
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Ronald Reagan UCLA Medical Center, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
A Study of PHN-012 in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- PHN-012-001 Site, Los Angeles
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Namoota walitti qabaa jiraSadarkaa 2/3
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- UCLA Department of Medicine - Hematology/Oncology, Los Angeles
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Namoota walitti qabaa jiraSadarkaa 3
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Namoota walitti qabaa jiraSadarkaa 3
- Investigative Site US027, Los Angeles
- Investigative Site US036, Los Angeles
- Investigative Site US048, Los Angeles
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Cedars-Sinai - Cedars-Sinai Medical Center, Los Angeles
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- UCLA Hematology/Oncology- Santa Monica, Los Angeles
CREO - Microwave Ablation Feasibility Study
Namoota walitti qabaa jira
- Cedars Sinai, Los Angeles
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Children's Hospital Los Angeles, Los Angeles
- Cedars Sinai Medical Center, Los Angeles
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- USC/Norris Comprehensive Cancer Center, Los Angeles
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Namoota walitti qabaa jiraQorannoo ilaalaa
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Namoota walitti qabaa jiraSadarkaa 2
- START- Los Angeles, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
Namoota walitti qabaa jira
- Cedars-Sinai, Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
Namoota walitti qabaa jiraSadarkaa 1
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- ULCA, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- The Angeles Clinic and Research Institute, Los Angeles
ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- California Research Institute, Los Angeles
Pancreatic Cancer Early Detection Consortium
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Cedars-Sinai Medical Center, Los Angeles
- UCLA Health, Los Angeles
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Namoota walitti qabaa jiraSadarkaa 2
- Cedars-Sinai Medical Center, Los Angeles
EXoPERT EMERALD Clinical Study
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- City of Hope Duarte Cancer Center, Los Angeles
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Namoota walitti qabaa jiraSadarkaa 1
- Cedars-Sinai Medical Center, Los Angeles
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Namoota walitti qabaa jiraSadarkaa 1
- USC Norris Comprehensive Cancer Center /ID# 279603, Los Angeles
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Namoota walitti qabaa jiraSadarkaa 1/2
- UCLA Medical Center, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Namoota walitti qabaa jira
- Oncology Institute for Hope and Innovation, Los Angeles
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Cedars-Sinai Medical Center, Los Angeles
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Namoota walitti qabaa jira
- Cedars-Sinai Medical Center, Los Angeles
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Namoota walitti qabaa jiraSadarkaa 2
- Ohio State University-Telemedicine, Los Angeles
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Cedars Sinai Medical Center, Los Angeles
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Keck School of Medicine of USC, Los Angeles
- UCLA, Los Angeles
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 2
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
Qorannoo Kansarii Pancreas magaalota biroo keessatti
- Houston, TXQorannoo 61
- New York City, NYQorannoo 60
- Boston, MAQorannoo 43
- Nashville, TNQorannoo 39
- St. Louis, MOQorannoo 33
- Arlington, VAQorannoo 33
- Baltimore, MDQorannoo 31
- San Antonio, TXQorannoo 31
- Philadelphia, PAQorannoo 26
- Tampa, FLQorannoo 26
- Durham, NCQorannoo 24
- San Diego, CAQorannoo 24
Qorannoo biroo Los Angeles keessatti
- Kansara Qara'a Non-Small CellQorannoo 87
- Saree (Gosoota Hunda)Qorannoo 74
- Saree OljooQorannoo 73
- Kansarii ProstateQorannoo 61
- Kansarii ColorectalQorannoo 59
- Kansara MetastatikiiQorannoo 57
- Kansarii OvariiQorannoo 50
- Dhibee QaraQorannoo 45
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 42
- Kansa EndometiriyaaliiQorannoo 34
- MelanomaQorannoo 34
- Kansaar Onnee Triple-NegativeQorannoo 27
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.